Cart
sales@molnova.com
Tricin 7-O-glucuronide
CAS No. 32769-02-1
Tricin 7-O-glucuronide ( —— )
Catalog No. M21876 CAS No. 32769-02-1
Tricin 7-O-glucuronide is an Alfalfa (Medicago sativa L.) flavonoid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTricin 7-O-glucuronide
-
NoteResearch use only, not for human use.
-
Brief DescriptionTricin 7-O-glucuronide is an Alfalfa (Medicago sativa L.) flavonoid.
-
DescriptionTricin 7-O-glucuronide is an Alfalfa (Medicago sativa L.) flavonoid.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number32769-02-1
-
Formula Weight506.41
-
Molecular FormulaC??H??O??
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]1[C@H](O)[C@@H](C(O)=O)O[C@@H](OC2=CC(O)=C(C(C=C(C3=CC(OC)=C(O)C(OC)=C3)O4)=O)C4=C2)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li C, et al. Simultaneous determination of seven flavonoids, two phenolic acids and two cholesterines in Tanreqing injection by UHPLC-MS/MS. J Pharm Biomed Anal. 2019 Jan 30;163:105-112.
molnova catalog
related products
-
trans-Petroselinic A...
Trans-Petroselinic acid, the trans isomer of petroselinic acid and an isomer of oleic acid, is detected in the milk fat of cows, goats, and ewes, as well as human breast milk.
-
Demethoxycurcumin
Demethoxycurcumin is a potential additive natural product in combination with chemotherapeutic agents in drug-resistant cancers.
-
RMC-6291
RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models .
